Prolonged survival of guinea pig-to-rat heart xenografts using repeated low doses of cobra venom factor.
Tavakoli
R
R
Laboratoire de Recherche Chirurgicale, UER Cochin Port-Royal, Paris, France.
Michel
A
A
Cardoso
J
J
Ayani
E
E
Maillet
F
F
Fontaliran
F
F
Crougneau
S
S
Weill
B
B
Houssin
D
D
D000818:Animals; D003165:Complement System Proteins / Q000032:analysis; D004224:Diterpenes; D004546:Elapid Venoms / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D046934:Ginkgolides; D006084:Graft Rejection; D006085:Graft Survival / Q000276:immunology*; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006461:Hemolysis; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007783:Lactones / Q000627:therapeutic use; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000473:pathology
D004224:Diterpenes; D004546:Elapid Venoms; D005343:Fibrinolytic Agents; D046934:Ginkgolides; D007166:Immunosuppressive Agents; D007783:Lactones; C016310:cobra venom factor; D003165:Complement System Proteins; C045856:ginkgolide B